Functional Genomic Screening Independently Identifies CUL3 as a Mediator of Vemurafenib Resistance via Src-Rac1 Signaling Axis.
Saved in:
| Title: | Functional Genomic Screening Independently Identifies CUL3 as a Mediator of Vemurafenib Resistance via Src-Rac1 Signaling Axis. |
|---|---|
| Authors: | Vanneste M; Department of Molecular Physiology and Biophysics, Roy J. and Lucille A. Carver College of Medicine, The University of Iowa, Iowa City, IA, United States., Feddersen CR; Department of Anatomy and Cell Biology, Carver College of Medicine, University of Iowa, Iowa City, IA, United States., Varzavand A; Department of Biology, College of Liberal Arts and Sciences, University of Iowa, Iowa City, IA, United States., Zhu EY; Department of Anatomy and Cell Biology, Carver College of Medicine, University of Iowa, Iowa City, IA, United States., Foley T; Carver College of Medicine, University of Iowa, Iowa City, IA, United States., Zhao L; Department of Molecular Physiology and Biophysics, Roy J. and Lucille A. Carver College of Medicine, The University of Iowa, Iowa City, IA, United States., Holt KH; Viral Vector Core Facility, Carver College of Medicine, University of Iowa, Iowa City, IA, United States., Milhem M; Department of Internal Medicine, Carver College of Medicine, University of Iowa, Iowa City, IA, United States.; Holden Comprehensive Cancer Center, University of Iowa, Iowa City, IA, United States., Piper R; Department of Molecular Physiology and Biophysics, Roy J. and Lucille A. Carver College of Medicine, The University of Iowa, Iowa City, IA, United States.; Holden Comprehensive Cancer Center, University of Iowa, Iowa City, IA, United States., Stipp CS; Department of Biology, College of Liberal Arts and Sciences, University of Iowa, Iowa City, IA, United States.; Holden Comprehensive Cancer Center, University of Iowa, Iowa City, IA, United States., Dupuy AJ; Department of Anatomy and Cell Biology, Carver College of Medicine, University of Iowa, Iowa City, IA, United States.; Holden Comprehensive Cancer Center, University of Iowa, Iowa City, IA, United States., Henry MD; Department of Molecular Physiology and Biophysics, Roy J. and Lucille A. Carver College of Medicine, The University of Iowa, Iowa City, IA, United States.; Holden Comprehensive Cancer Center, University of Iowa, Iowa City, IA, United States.; Department of Radiation Oncology, Roy J. and Lucille A. Carver College of Medicine, The University of Iowa, Iowa City, IA, United States.; Department of Pathology, Roy J. and Lucille A. Carver College of Medicine, The University of Iowa, Iowa City, IA, United States.; Department of Urology, Roy J. and Lucille A. Carver College of Medicine, The University of Iowa, Iowa City, IA, United States. |
| Source: | Frontiers in oncology [Front Oncol] 2020 Apr 03; Vol. 10, pp. 442. Date of Electronic Publication: 2020 Apr 03 (Print Publication: 2020). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 32346533 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Functional Genomic Screening Independently Identifies CUL3 as a Mediator of Vemurafenib Resistance via Src-Rac1 Signaling Axis. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Vanneste+M%22">Vanneste M</searchLink>; Department of Molecular Physiology and Biophysics, Roy J. and Lucille A. Carver College of Medicine, The University of Iowa, Iowa City, IA, United States.<br /><searchLink fieldCode="AU" term="%22Feddersen+CR%22">Feddersen CR</searchLink>; Department of Anatomy and Cell Biology, Carver College of Medicine, University of Iowa, Iowa City, IA, United States.<br /><searchLink fieldCode="AU" term="%22Varzavand+A%22">Varzavand A</searchLink>; Department of Biology, College of Liberal Arts and Sciences, University of Iowa, Iowa City, IA, United States.<br /><searchLink fieldCode="AU" term="%22Zhu+EY%22">Zhu EY</searchLink>; Department of Anatomy and Cell Biology, Carver College of Medicine, University of Iowa, Iowa City, IA, United States.<br /><searchLink fieldCode="AU" term="%22Foley+T%22">Foley T</searchLink>; Carver College of Medicine, University of Iowa, Iowa City, IA, United States.<br /><searchLink fieldCode="AU" term="%22Zhao+L%22">Zhao L</searchLink>; Department of Molecular Physiology and Biophysics, Roy J. and Lucille A. Carver College of Medicine, The University of Iowa, Iowa City, IA, United States.<br /><searchLink fieldCode="AU" term="%22Holt+KH%22">Holt KH</searchLink>; Viral Vector Core Facility, Carver College of Medicine, University of Iowa, Iowa City, IA, United States.<br /><searchLink fieldCode="AU" term="%22Milhem+M%22">Milhem M</searchLink>; Department of Internal Medicine, Carver College of Medicine, University of Iowa, Iowa City, IA, United States.; Holden Comprehensive Cancer Center, University of Iowa, Iowa City, IA, United States.<br /><searchLink fieldCode="AU" term="%22Piper+R%22">Piper R</searchLink>; Department of Molecular Physiology and Biophysics, Roy J. and Lucille A. Carver College of Medicine, The University of Iowa, Iowa City, IA, United States.; Holden Comprehensive Cancer Center, University of Iowa, Iowa City, IA, United States.<br /><searchLink fieldCode="AU" term="%22Stipp+CS%22">Stipp CS</searchLink>; Department of Biology, College of Liberal Arts and Sciences, University of Iowa, Iowa City, IA, United States.; Holden Comprehensive Cancer Center, University of Iowa, Iowa City, IA, United States.<br /><searchLink fieldCode="AU" term="%22Dupuy+AJ%22">Dupuy AJ</searchLink>; Department of Anatomy and Cell Biology, Carver College of Medicine, University of Iowa, Iowa City, IA, United States.; Holden Comprehensive Cancer Center, University of Iowa, Iowa City, IA, United States.<br /><searchLink fieldCode="AU" term="%22Henry+MD%22">Henry MD</searchLink>; Department of Molecular Physiology and Biophysics, Roy J. and Lucille A. Carver College of Medicine, The University of Iowa, Iowa City, IA, United States.; Holden Comprehensive Cancer Center, University of Iowa, Iowa City, IA, United States.; Department of Radiation Oncology, Roy J. and Lucille A. Carver College of Medicine, The University of Iowa, Iowa City, IA, United States.; Department of Pathology, Roy J. and Lucille A. Carver College of Medicine, The University of Iowa, Iowa City, IA, United States.; Department of Urology, Roy J. and Lucille A. Carver College of Medicine, The University of Iowa, Iowa City, IA, United States. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101568867%22">Frontiers in oncology</searchLink> [Front Oncol] 2020 Apr 03; Vol. 10, pp. 442. <i>Date of Electronic Publication: </i>2020 Apr 03 (<i>Print Publication: </i>2020). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101568867 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2234-943X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222234943X%22">2234943X </searchLink><i>NLM ISO Abbreviation: </i>Front Oncol <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32346533 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fonc.2020.00442 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 442 Titles: – TitleFull: Functional Genomic Screening Independently Identifies CUL3 as a Mediator of Vemurafenib Resistance via Src-Rac1 Signaling Axis. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Vanneste M – PersonEntity: Name: NameFull: Feddersen CR – PersonEntity: Name: NameFull: Varzavand A – PersonEntity: Name: NameFull: Zhu EY – PersonEntity: Name: NameFull: Foley T – PersonEntity: Name: NameFull: Zhao L – PersonEntity: Name: NameFull: Holt KH – PersonEntity: Name: NameFull: Milhem M – PersonEntity: Name: NameFull: Piper R – PersonEntity: Name: NameFull: Stipp CS – PersonEntity: Name: NameFull: Dupuy AJ – PersonEntity: Name: NameFull: Henry MD IsPartOfRelationships: – BibEntity: Dates: – D: 03 M: 04 Text: 2020 Apr 03 Type: published Y: 2020 Identifiers: – Type: issn-print Value: 2234-943X Numbering: – Type: volume Value: 10 Titles: – TitleFull: Frontiers in oncology Type: main |
| ResultId | 1 |